(87 days)
Not Found
No
The summary describes a microprocessor-controlled instrument that performs standard audiological tests (OAEs, tympanometry, acoustic reflex) and stores/displays data. There is no mention of AI, ML, or any related concepts in the device description, intended use, or performance studies. The focus is on standard signal processing and data handling.
No
The device is indicated for testing and measuring functions of the ear, not for treating conditions.
Yes
The device is indicated for "testing of cochlear and middle ear function" and measures "otoacoustic emissions (OAEs), tympanometry, and acoustic reflex," which are diagnostic measurements for assessing hearing and middle ear health.
No
The device description explicitly states it is a "microprocessor-controlled instrument" and is "manufactured and delivered completely assembled," indicating it is a hardware device with embedded software, not a standalone software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The ER35 ERO•SCAN Pro Hearing Test System measures otoacoustic emissions, tympanometry, and acoustic reflex. These are measurements taken in vivo (within the living body) by placing a probe in the ear canal.
- Lack of Sample Analysis: The device does not analyze any biological samples taken from the patient.
Therefore, the ER35 is a diagnostic device, but it is not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The ER35 is intended to be a test instrument that measures otoacoustic emissions, tympanic membrane performance (tympanometry), and acoustic reflex.
The ER35 ERO•SCAN Pro Hearing Test System is indicated for testing of cochlear and middle ear function in infants, children, and adults by measuring otoacoustic emissions (OAEs), tympanometry, and acoustic reflex.
Product codes (comma separated list FDA assigned to the subject device)
EWO, ETY
Device Description
The ER35 is a microprocessor-controlled instrument designed to screen otoacoustic emissions, tympanic membrane performance, and acoustic reflex. Test information is stored in memory, displayed on a graphic LCD, and can be printed by a printer or stored on a computer. The product is manufactured and delivered completely assembled to the retailer using materials and techniques widely used by manufacturers of hearing devices.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Cochlear and middle ear
Indicated Patient Age Range
Infants, children, and adults
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical and clinical validation was performed in accordance with recognized consensus standards for this type of device. The ER35 has been demonstrated to be in compliance with the following performance and safety standards:
- . Specifications for Instruments to Measure Aural Impedance and Admittance (Aural Acoustic Emissions) (ANSI S3.39-1987 (R2007)), American National Standards Institute, New York, 1996;
- Medical Electrical Equipment, Part 1: General . Requirements for Safety (IEC 60601-1:2000), International Electrotechnical Commission, Geneva, 2000; and
- . Specification for Audiometers (Dental/ENT) (ANSI S3.6-2004), American National Standards Institute, New York, 2004.
The ER35 is also in compliance with the following voluntary performance and safety standards: Instruments for the Measurement of Aural Acoustic Impedance / Admittance (IEC 60645-5:2004), International Electrotechnical Commission, Geneva, 2004.
Subjects tested included both male and female participants, an appropriate age range, and variable audiometric profiles (i.e., subjects with normal range hearing and impaired hearing function). No adverse effects or complications occurred. Performance data collected supports a substantial equivalence determination.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K980533, K010165, K000097, K994254
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 874.1050 Audiometer.
(a)
Identification. An audiometer or automated audiometer is an electroacoustic device that produces controlled levels of test tones and signals intended for use in conducting diagnostic hearing evaluations and assisting in the diagnosis of possible otologic disorders.(b)
Classification. Class II. Except for the otoacoustic emission device, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, if it is in compliance with American National Standard Institute S3.6-1996, “Specification for Audiometers,” and subject to the limitations in § 874.9.
0
Etymotic Research, Inc. Page 7
.
3.0 510(K) SUMMARY
| Date Prepared: | December 5, 2011 |
|---|---|
| ---------------- | ------------------ |
Submitter Information:
| Company Name: | Etymotic Research, Inc. |
|---|---|
| Company Address: | Etymotic Research, Inc. |
| 61 Martin Lane | |
| Elk Grove Village, IL 60007 | |
| Contact Person: | Steve Iseberg |
| Manager of Instrumentation Products | |
| Etymotic Research, Inc. | |
| Tel: (847) 228-0006 | |
| Fax: (847) 228-6836 | |
| s iseberg@etymotic.com |
Device Information:
| Trade Name: | ER35 ERO-SCAN Pro Hearing Test System |
|---|---|
| Common Name: | ER35 ERO-SCAN Pro (ER35) |
| Classification Name: | Audiometer and Auditory Impedance Tester |
| Device Class: | Class II, 510(k) Exempt, 21 CFR §874.1050 |
| Class II, 21 CFR §874.1090 | |
| Predicate Devices: | ERO•SCAN Otoacoustic Test Instrument (K980533; |
| K010165) | |
| Etymotic Research, Inc. | |
| GSI 2000 (TympStar™) Middle Ear Analyzer (K000097) | |
| VIASYS Healthcare (formerly Grason-Stadler Inc.) | |
| Interacoustics AT235H Impedance Audiometer (K994254) | |
| Interacoustics A/S | |
| Device Description: | The ER35 is a microprocessor-controlled instrument |
| designed to screen otoacoustic emissions, tympanic | |
| membrane performance, and acoustic reflex. Test | |
| information is stored in memory, displayed on a graphic | |
| LCD, and can be printed by a printer or stored on a |
1
computer. The product is manufactured and delivered completely assembled to the retailer using materials and techniques widely used by manufacturers of hearing devices.
Intended Use: The ER35 is intended to be a test instrument that measures otoacoustic emissions, tympanic membrane performance (tympanometry), and acoustic reflex.
Indications for Use: The ER35 ERO•SCAN Pro Hearing Test System is indicated for testing of cochlear and middle ear function in infants, children, and adults by measuring otoacoustic emissions (OAEs), tympanometry, and acoustic reflex.
Comparison to Predicate Device:
All device parameters are similar for the product which is the subject of this 510(k) and the predicate devices. The intended use (including patient population) for the ER35 is consistent with those of the cited predicate devices.
Technological characteristics (i.e., design, material, and energy source) are identical to the ERO.SCAN Otoacoustic Test Instrument (K980533; K010165). The device is powered by 4 AA Alkaline cells, storing data (test records) via internal flash memory. The added functionality beyond OAEs does not affect the overall technological function and operation, compared to the predicate devices.
Certain performance specifications may vary compared to predicate devices, but in these cases, sufficient performance testing has been done to support substantial equivalence determination.
Non-clinical and clinical validation was performed in accordance with recognized consensus standards for this type of device. The ER35 has been demonstrated to be in compliance with the following performance and safety standards:
- . Specifications for Instruments to Measure Aural Impedance and Admittance (Aural Acoustic Emissions) (ANSI S3.39-1987 (R2007)), American National Standards Institute, New York, 1996;
Performance testing:
2
- Medical Electrical Equipment, Part 1: General . Requirements for Safety (IEC 60601-1:2000), International Electrotechnical Commission, Geneva, 2000; and
- . Specification for Audiometers (Dental/ENT) (ANSI S3.6-2004), American National Standards Institute, New York, 2004.
The ER35 is also in compliance with the following voluntary performance and safety standards: Instruments for the Measurement of Aural Acoustic Impedance / Admittance (IEC 60645-5:2004), International Electrotechnical Commission, Geneva, 2004.
Subjects tested included both male and female participants, an appropriate age range, and variable audiometric profiles (i.e., subjects with normal range hearing and impaired hearing function). No adverse effects or complications occurred. Performance data collected supports a substantial equivalence determination.
Conclusion:
The ER35 utilizes the same technology and has the same intended use as the cited predicate devices, and is therefore substantially equivalent (21 §CFR 807.92(a)(3)).
3
Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo features a stylized caduceus, a symbol often associated with healthcare, with three parallel lines forming the snake and staff. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the caduceus.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
DEC 1 6 2011
Etymotic Research, Inc. c/o Mr. Jack Kent Becker & Associates Consulting, Inc. 2001 Pennsylvania Avenue NW, Suite 950 Washington, DC 20006
Re: K112733
Trade/Device Name: ER35 ERO●SCAN Pro Hearing Test System Regulation Number: 21 CFR 874.1050 Regulation Name: Audiometer Regulatory Class: Class II Product Code: EWO: ETY Dated: September 20, 2011 Received: September 20, 2011
Dear Mr. Kent:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Jack Kent
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.html for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htmi for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Malvina B. Eydelman, M.D.
Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
2.0 STATEMENT OF INDICATIONS FOR USE
510(k) Number (if known): K112733
Device Name:
ER35 ERO.SCAN Pro Hearing Test System
Indications for Use:
The ER35 ERO•SCAN Pro Hearing Test System is indicated for testing of cochlear and middle ear function in infants, children, and adults by measuring otoacoustic emissions (OAEs), tympanometry, and acoustic reflex.
Prescription Use X (Part 21 CFR §801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR $801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
(Division Sign-Off) Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices
KI12733 510(k) Number_